New Delhi, July 22: All India Institute of Medical Sciences in New Delhi will commence the second dose trial of Bharat Biotech's COVID-19 vaccine, Covaxin, for children aged 2-6 years.
Additionally, the results of clinical trials are expected to come in one month after the completion of trials of all age groups.
|